PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: R&D Investor Presentation, page-30

  1. 9,839 Posts.
    lightbulb Created with Sketch. 1258
    No that not what I heard nor most probably. We're getting a deal/deals rather than cap raise is my call. Yes they'll hold out for best deal to ensure they max it and avoid highlighting they're short of funding to completion
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.